LOS ANGELES , Aug. 26, 2025 /PRNewswire/ -- Glancy Prongay & Murray LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against Centene Corporation ("Centene" or the "Company") (NYSE: CNC). IF YOU SUFFERED A LOSS ON YOUR CENTENE INVESTMENTS, CLICK HERE BEFORE SEPTEMBER 8, 2025 (LEAD PLAINTIFF DEADLINE) TO PARTICIPATE IN THE SECURITIES FRAUD LAWSUIT What Is The Lawsuit About?

image for news Centene Corporation (CNC) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

LOS ANGELES, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP reminds investors of the upcoming September 30, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Novo Nordisk A/S (“Novo Nordisk” or the “Company”) (NYSE: NVO) securities between May 7, 2025, to July 28, 2025, inclusive (the “Class Period”).

image for news Deadline Alert: Novo Nordisk A/S (NVO) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit

LOS ANGELES , Aug. 26, 2025 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to CTO Realty Growth, Inc. ("CTO" or the "Company") (NYSE: CTO) have opportunity to lead the securities fraud class action lawsuit.

image for news CTO Realty Growth, Inc. (CTO) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

Lynch Carpenter Investigates Healthcare Services Group Data Breach Claims — Neutral

HCSG   GlobeNewsWire — August 26, 2025

PITTSBURGH, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Healthcare Services Group, Inc. (“HSG”), recently announced a cybersecurity incident, which impacted the personal information of hundreds of thousands of individuals. The information potentially impacted in the data breach includes names, Social Security numbers, driver's license numbers, state identification numbers, financial account details, and other personally identifiable information (“PII”).

image for news Lynch Carpenter Investigates Healthcare Services Group Data Breach Claims

Nvidia's new ‘robot brain' is now on sale — Positive

NVDA   The Street — August 26, 2025

The $3,499 chip allows customers to create robots. Transcript: CAROLINE WOODS: NVIDIA is giving robots an upgrade.

image for news Nvidia's new ‘robot brain' is now on sale

Coca-Cola vs. Monster Beverage: Which Stock Offers Refreshing Returns? — Positive

KO  MNST   Zacks Investment Research — August 26, 2025

KO's global scale and steady cash flow meet MNST's rapid growth and global energy drink dominance in a showdown of growth, innovation and market strategy.

image for news Coca-Cola vs. Monster Beverage: Which Stock Offers Refreshing Returns?

Best Natural and Organic Food Stocks for Investors in 2025 — Positive

HAIN  SFM  UNFI  VITL   Zacks Investment Research — August 26, 2025

Hain Celestial, Vital Farms, Sprouts Farmers and United Natural Foods are betting big on organic, clean-label foods and redefining what's healthy on store shelves.

image for news Best Natural and Organic Food Stocks for Investors in 2025

TTD vs. AMZN: Which Ad-Tech Stock is the Smarter Buy Now? — Positive

AMZN  TTD   Zacks Investment Research — August 26, 2025

Amazon's surging ad revenues and diversified growth give it an edge over The Trade Desk's ad-tech reliance.

image for news TTD vs. AMZN: Which Ad-Tech Stock is the Smarter Buy Now?

The head of the Federal Aviation Administration said Tuesday the agency plans to conduct tabletop exercises with Boeing before it will consider lifting the 38-plane per month cap on 737 MAX production.

image for news US FAA plans table-top exercises before it may lift Boeing 737 MAX production cap

What's Driving Altria Group's Growth in OCI for Smokeables? — Neutral

MO   Zacks Investment Research — August 26, 2025

MO's smokeable margins jumped 2.9 percentage points to 64.5% as pricing power and cost cuts offset sharp volume declines.

image for news What's Driving Altria Group's Growth in OCI for Smokeables?

ENPH or SEDG: Which Stock Shines Brighter in the Solar Energy Market? — Positive

ENPH  SEDG   Zacks Investment Research — August 26, 2025

Enphase Energy and SolarEdge showcase growth, new products and challenges as investors weigh opportunities in the solar energy market.

image for news ENPH or SEDG: Which Stock Shines Brighter in the Solar Energy Market?

Here's What Investors Must Know Ahead of Williams-Sonoma's Q2 Release — Positive

WSM   Zacks Investment Research — August 26, 2025

WSM heads into Q2 earnings with stable estimates, digital expansion and margin gains expected to offset housing headwinds.

image for news Here's What Investors Must Know Ahead of Williams-Sonoma's Q2 Release

Graco Stock Exhibits Strong Prospects Despite Persisting Headwinds — Neutral

GGG   Zacks Investment Research — August 26, 2025

GGG's Industrial and Expansion Markets strength, acquisitions and shareholder returns fuel its 2025 momentum.

image for news Graco Stock Exhibits Strong Prospects Despite Persisting Headwinds

Palantir: The Greater Risk Lies In Not Being Exposed To It — Positive

PLTR   Seeking Alpha — August 26, 2025

Palantir Technologies Inc. represents a leveraged bet on AI's exponential growth toward full automation, positioning it as a winner in the AI "application layer." Palantir's position today is similar to Nvidia's dominance in AI hardware in the last 5 years. For AI bulls, not being exposed to PLTR is a risk in itself. AI may plateau, grow linearly, or exponentially; the latter option supports Palantir's acceleration, with TCV growth signaling potential 100%+ YoY revenue increases.

image for news Palantir: The Greater Risk Lies In Not Being Exposed To It

Allarity Therapeutics (NASDAQ:ALLR) shares more than doubled after the pharmaceutical firm annoucned that its investigational therapy for advanced ovarian cancer, stenoparib, has received Fast Track Designation from the US Food and Drug Administration (FDA). The FDA's Fast Track program is designed to speed the development and review of drugs that target serious conditions and address unmet medical needs.

image for news Allarity Therapeutics shares pop as ovarian cancer therapy recieves FDA Fast Track Designation

Here's Why You Should Consider Investing in RBC Bearings Stock Now — Positive

RBC   Zacks Investment Research — August 26, 2025

RBC is gaining traction from aerospace and industrial strength, a healthy backlog and accretive acquisitions.

image for news Here's Why You Should Consider Investing in RBC Bearings Stock Now

Northrop Secures a Deal for Joint Domain Command and Control System — Positive

NOC   Zacks Investment Research — August 26, 2025

NOC wins a $99.1M contract to develop advanced command and control systems for the U.S. Department of Defense.

image for news Northrop Secures a Deal for Joint Domain Command and Control System

S&P Cotality Case-Shiller Index Records Annual Gain in June 2025 — Neutral

SPGI   PRNewsWire — August 26, 2025

The U.S. National Index, the 20-City Composite, and the 10-City Composite continue to display growth with 1.9%, 2.1% and 2.6%, respectively. Housing wealth erodes in real terms for second consecutive month, with home price gains of 1.9% trailing consumer inflation of 2.7%.

image for news S&P Cotality Case-Shiller Index Records Annual Gain in June 2025

Joby's Sky Limo Vs. Archer's Flying Taxi - Pick Your Future — Neutral

JOBY   Benzinga — August 26, 2025

Flying cars may still sound like science fiction, but in the battle between Joby Aviation Inc JOBY and Archer Aviation Inc ACHR, the future is already diverging into two very different business models. On one side, Joby is positioning itself as the "sky limo" of tomorrow—fast, sleek, and aimed at premium intercity travel.

image for news Joby's Sky Limo Vs. Archer's Flying Taxi - Pick Your Future

Lloyds and Barclays most preferred as UK banks 'still offer upside' and returns — Positive

BCS  LYG   Proactive Investors — August 26, 2025

Valuations across UK domestic banks have recovered strongly with a 140% total shareholder return since the start of 2024 but the sector still offers value, even if it is slightly less attractive than before, analysts at Jefferies believe. The implied cost of equity (COE) is now below 14%, which makes the investment case "less compelling" than before, the broker remains constructive on the sector and sees Lloyds Banking Group PLC (LSE:LLOY) and Barclays PLC (LSE:BARC) over NatWest Group PLC (LSE:NWG).

image for news Lloyds and Barclays most preferred as UK banks 'still offer upside' and returns